Search
Related
Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas.
Paik PK, Johnson ML, D'Angelo SP, Sima CS, Ang D, Dogan S, Miller VA, Ladanyi M, Kris MG, Riely GJ.
Cancer. 2012 May 17. doi: 10.1002/cncr.27637. [Epub ahead of print
22605530
[PubMed - as supplied by publisher] nohighlight
Related citations
Detection of EGFR Somatic Mutations in Non-Small Cell Lung Cancer (NSCLC) Using a Novel Mutant-Enriched Liquidchip (MEL) Technology.
Zhang L, Yang H, Zhao Y, Liu W, Wu S, He J, Luo X, Zhu Z, Xu J, Zhou Q, Ren-Heidenreich L.
Curr Drug Metab. 2012 May 16. [Epub ahead of print
22591345
[PubMed - as supplied by publisher] nohighlight
Related citations
Differential Sensitivity of Glioma- versus Lung Cancer-Specific EGFR Mutations to EGFR Kinase Inhibitors.
Vivanco I, Robins HI, Rohle D, Campos C, Grommes C, Nghiemphu PL, Kubek S, Oldrini B, Chheda MG, Yannuzzi N, Tao H, Zhu S, Iwanami A, Kuga D, Dang J, Pedraza A, Brennan CW, Heguy A, Liau LM, Lieberman F, Yung WK, Gilbert MR, Reardon DA, Drappatz J, Wen PY, Lamborn KR, Chang SM, Prados MD, Fine HA, Horvath S, Wu N, Lassman AB, Deangelis LM, Yong WH, Kuhn JG, Mischel PS, Mehta MP, Cloughesy TF, Mellinghoff IK.
Cancer Discov. 2012 May;2(5):458-471. Epub 2012 Mar 31
22588883
[PubMed - as supplied by publisher] nohighlight
Related citations
Occupy EGFR.
Park JH, Lemmon MA.
Cancer Discov. 2012 May;2(5):398-400
22588876
[PubMed - in process] nohighlight
Related citations
Screening for Germline EGFR T790M Mutations Through Lung Cancer Genotyping.
Oxnard GR, Miller VA, Robson ME, Azzoli CG, Pao W, Ladanyi M, Arcila ME.
J Thorac Oncol. 2012 Jun;7(6):1049-52
22588155
[PubMed - in process] nohighlight
Related citations
Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial.
Oizumi S, Kobayashi K, Inoue A, Maemondo M, Sugawara S, Yoshizawa H, Isobe H, Harada M, Kinoshita I, Okinaga S, Kato T, Harada T, Gemma A, Saijo Y, Yokomizo Y, Morita S, Hagiwara K, Nukiwa T.
Oncologist. 2012 May 11. [Epub ahead of print
22581822
[PubMed - as supplied by publisher] nohighlight
Related citations
Successful erlotinib rechallenge for leptomeningeal metastases of lung adenocarcinoma after erlotinib-induced interstitial lung disease: A case report and review of the literature.
Togashi Y, Masago K, Hamatani Y, Sakamori Y, Nagai H, Kim YH, Mishima M.
Lung Cancer. 2012 May 11. [Epub ahead of print
22579408
[PubMed - as supplied by publisher] nohighlight
Related citations
EGFR exon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patients.
Yang SY, Yang TY, Li YJ, Chen KC, Liao KM, Hsu KH, Tsai CR, Chen CY, Hsu CP, Hsia JY, Chuang CY, Tsai YH, Chen KY, Huang MS, Su WC, Chen YM, Hsiung CA, Shen CY, Chang GC, Yang PC, Chen CJ.
Int J Cancer. 2012 May 10. doi: 10.1002/ijc.27630. [Epub ahead of print
22573488
[PubMed - as supplied by publisher] nohighlight
Related citations
Relationship between epidermal growth factor receptor gene mutation and copy number in Chinese patients with non-small cell lung cancer.
Zhang LJ, Cai L, Li Z, Wang WP, Guo K, Shao JY, Wang JY, Yu H, Rong TH.
Chin J Cancer. 2012 May 8. doi: 10.5732/cjc.011.10409. [Epub ahead of print
22572014
[PubMed - as supplied by publisher] Free Article nohighlight
Related citations
Association of EGFR mutation or ALK rearrangement with expression of DNA repair and synthesis genes in never-smoker women with pulmonary adenocarcinoma.
Ren S, Chen X, Kuang P, Zheng L, Su C, Li J, Li B, Wang Y, Liu L, Hu Q, Zhang J, Tang L, Li X, Zhou C, Schmid-Bindert G.
Cancer. 2012 May 8. doi: 10.1002/cncr.27603. [Epub ahead of print
22569898
[PubMed - as supplied by publisher] nohighlight
Related citations
Epidermal growth factor receptor inhibitors in non-small cell lung cancer: current status and future perspectives.
Zükin M.
Rev Assoc Med Bras. 2012 Apr;58(2):263-8
22569624
[PubMed - in process] Free Article nohighlight
Related citations
Guidelines for biomarker testing in advanced non-small-cell lung cancer. A National Consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).
Garrido P, de Castro J, Concha A, Felip E, Isla D, López-Ríos F, Paz-Ares L, Ramírez J, Sanz J, Gómez JJ.
Clin Transl Oncol. 2012 May;14(5):338-49
22551539
[PubMed - in process] nohighlight
Related citations
Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial.
Jänne PA, Wang X, Socinski MA, Crawford J, Stinchcombe TE, Gu L, Capelletti M, Edelman MJ, Villalona-Calero MA, Kratzke R, Vokes EE, Miller VA.
J Clin Oncol. 2012 Apr 30. [Epub ahead of print
22547605
[PubMed - as supplied by publisher] nohighlight
Related citations
EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma.
Smits AJ, Kummer JA, Hinrichs JW, Herder GJ, Scheidel-Jacobse KC, Jiwa NM, Ruijter TE, Nooijen PT, Looijen-Salamon MG, Ligtenberg MJ, Thunnissen FB, Heideman DA, de Weger RA, Vink A.
Cell Oncol (Dordr). 2012 Apr 12. [Epub ahead of print
22528563
[PubMed - as supplied by publisher] nohighlight
Related citations
Effusion Immunocytochemistry as an Alternative Approach for the Selection of First-Line Targeted Therapy in Advanced Lung Adenocarcinoma.
Tsai TH, Wu SG, Chang YL, Wu CT, Tsai MF, Wei PF, Yang CH, Yu CJ, Yang PC, Shih JY.
J Thorac Oncol. 2012 Jun;7(6):993-1000
22525557
[PubMed - as supplied by publisher] nohighlight
Related citations
RET finger protein expression is associated with prognosis in lung cancer with epidermal growth factor receptor mutations.
Iwakoshi A, Murakumo Y, Kato T, Kitamura A, Mii S, Saito S, Yatabe Y, Takahashi M.
Pathol Int. 2012 May;62(5):324-30. doi: 10.1111/j.1440-1827.2012.02797.x. Epub 2012 Mar 27
22524660
[PubMed - in process] nohighlight
Related citations
Frequent EGFR Mutations in NSCLC Presenting with Miliary Intrapulmonary Carcinomatosis.
Wu SG, Hu FC, Chang YL, Lee YC, Yu CJ, Chang YC, Wu JY, Shih JY, Yang PC.
Eur Respir J. 2012 Apr 20. [Epub ahead of print
22523351
[PubMed - as supplied by publisher] nohighlight
Related citations
EGFR Somatic Mutations in Lung Tumors: Radon Exposure and Passive Smoking in Former- and Never-Smoking U.S. Women.
Taga M, Mechanic LE, Hagiwara N, Vähäkangas KH, Bennett WP, Alavanja MC, Welsh JA, Khan MA, Lee A, Diasio R, Edell E, Bungum A, Jang JS, Yang P, Jen J, Harris CC.
Cancer Epidemiol Biomarkers Prev. 2012 May 9. [Epub ahead of print
22523180
[PubMed - as supplied by publisher] nohighlight
Related citations
EGFR mutations as a predictive marker of cytotoxic chemotherapy.
Park JH, Lee SH, Keam B, Kim TM, Kim DW, Yang SC, Kim YW, Heo DS.
Lung Cancer. 2012 Apr 20. [Epub ahead of print
22521649
[PubMed - as supplied by publisher] nohighlight
Related citations
[Secondary gliosarcoma: Case report].
Tahri R, Boulahroud O, Setti K, Oukabli M, El Ochi MR, Akhaddar A, Boucetta M, Albouzidi A.
Ann Pathol. 2012 Apr;32(2):147-50. Epub 2012 Mar 20. French.
22520611
[PubMed - in process] nohighlight
Related citations